Stay updated on Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check26 days agoChange DetectedThe study’s record history now indicates an update to its references. A sitewide NIH notice about replacing “Artificial Intelligence” with “Super Intelligence” also appears.SummaryDifference0.5%

- Check33 days agoChange DetectedThe ClinicalTrials.gov site footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check40 days agoChange DetectedThe ClinicalTrials.gov page footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded a new system revision entry, Revision: v3.7.0, to the study record history and removed the previous Revision: v3.6.6 entry. This reflects a platform update affecting how revisions are labeled in the history view, not changes to the study data.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision: v3.6.6 was added to replace v3.6.5 in the record history, indicating a software update to the page's revision-tracking UI.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial page.